Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Rajapakse, Niwanthi W ^a   Roman, Richard J ^b   Falck, John R ^c   Oliver, Jeremy J ^a   Evans, Roger G ^a  

^a MONASH UNIVERSITY   (Australia)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Cytochrome P 450 enzyme system; Kidney cortex; Kidney medulla; Renal circulation; Vasopressin

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ANGIOTENSIN; CYTOCHROME P450 INHIBITOR; DIHYDROXYICOSATRIENOIC ACID; EPOXYICOSATRIENOIC ACID; ICOSATRIENOIC ACID; N METHYLSULFONYL 6 (2 PROPARGYLOXYPHENYL)HEXANAMIDE; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN[2 PHENYLALANINE 3 ISOLEUCINE 8 ORNITHINE]; AMIDE; ANGIOTENSIN II; ARACHIDONATE EPOXYGENASE; CYTOCHROME P450; DRUG DERIVATIVE; ENZYME INHIBITOR; ICOSANOID; MIXED FUNCTION OXIDASE; N-METHYLSULFONYL-6-(2-PROPARGYLOXYPHENYL)HEXANAMIDE; ORNIPRESSIN; OXYGENASE; PROSTAGLANDIN OMEGA HYDROXYLASES; VASOCONSTRICTOR AGENT; VASOPRESSIN RECEPTOR; VASOPRESSIN, PHE(2) ILE(3) ORN(8); VASOPRESSIN, PHE(2)-ILE(3)-ORN(8)-;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY HOMOGENATE; KIDNEY MEDULLA; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR UPREGULATION; RENAL ARTERY; SYNTHESIS; VASOCONSTRICTION; ANESTHESIA; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; KIDNEY CIRCULATION; METABOLISM; VASCULARIZATION;

AMIDES; ANESTHESIA; ANGIOTENSIN II; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; ENZYME INHIBITORS; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MIXED FUNCTION OXYGENASES; ORNIPRESSIN; OXYGENASES; RABBITS; RECEPTORS, VASOPRESSIN; RENAL ARTERY; RENAL CIRCULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 3042847689     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00555.2002     Document Type: Article

References (49)

1. Alonso-Galicia M, Maier KG, Greene AS, Cowley AW Jr, and Roman RJ. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283: R60-R68, 2002.
2. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002.
3. Badyńska Grzelec-Mojzesowicz M and Sadowski J. Prostaglandins but not nitric oxide protect renal medullary perfusion in anaesthetised rats receiving angiotensin II. J Physiol 548: 875-880, 2003.
4. Brand-Schieber E, Falck JR, and Schwartzman M. Selective inhibition of arachidonic acid epoxidation in vivo. J Physiol Pharmacol 51: 655-672, 2000.
5. 2-dependent and -independent pathways of arachidonate release from vascular smooth muscle cells. Biochem Pharmacol 53: 327-337, 1997.
6. Capdevila JH, Wei S, Yan J, Karara A, Jacobson HR, Falck JR, Guengerich FP, and DuBois RN. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem 267: 21720-21726, 1992.
7. Caroll MA, Balazy M, Margiotta P, Falck JR, and McGiff JC. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J Biol Chem 268: 12260-12266, 1993.
8. Carroll MA, Balazy M, Margiotta P, Huang DD, Falck JR, and McGiff JC. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am J Physiol Regul Integr Comp Physiol 271: R863-R869, 1996.
9. 1-receptors on regional kidney blood flow and glomerular arteriole diameters. J Hypertens 19: 649-657, 2001.
10. Cowley AW Jr. Role of the renal medulla in volume and arterial pressure regulation. Am J Physiol Regul Integr Comp Physiol 273: R1-R15, 1997.
11. Cowley AW Jr, Mori T, Mattson D, and Zou AP. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284: R1355-R1369, 2003.
12. 2 receptors in the renal cortical and medullary circulations of anesthetized rabbits. Hypertension 42: 200-205, 2003.
13. Evans RG, Day KH, Roman RJ, Hopp KH, and Anderson WP. Effects of intrarenal infusion of 17-octadecynoic acid on renal antihypertensive mechanisms in anesthetized rabbits. Am J Hypertens 11: 803-812, 1998.
14. Evans RG, Madden AC, and Denton KM. Diversity of responses of renal cortical and medullary blood flow to vasoconstrictors in conscious rabbits. Acta Physiol Scand 169: 297-308, 2000.
15. Evans RG, Stevenson KM, Bergström G, Denton KM, Madden AC, Gribben RL, Weekes SR, and Anderson WP. Sex differences in pressure diuresis/natriuresis in rabbits. Acta Physiol Scand 169: 309-316, 2000.
16. Falck JR, Belosludtsev Y, Kishta Reddy K, Malla Reddy K, Fiona Shortt M, and Chauhan K. Eicosanoid biosynthesis: differential inhibition of cytochrome P450 epoxygenase and ω-hydroxylase. Bioorg Med Chem Lett 7: 3053-3056, 1997.
17. Falck JR, Schueler VJ, Jacobson HR, Siddhanta AK, Pramanik B, and Capdevila J. Arachidonate epoxygenase: identification of epoxyeicosatrienoic acids in rabbit kidney. J Lipid Res 28: 840-846, 1987.
18. Franchini KG and Cowley AW Jr. Sensitivity of the renal medullary circulation to plasma vasopressin. Am J Physiol Regul Integr Comp Physiol 271: R647-R653, 1996.
19. 2 and modulation by lipoxygenase and P-450 pathways. Am J Physiol Renal Physiol 273: F274-F282, 1997.
20. 2s. J Biol Chem 277: 32807-32814, 2002.
21. Kohagura K, Endo Y, Ito O, Arima S, Omata K, and Ito S. Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole. Acta Physiol Scand 168: 107-112, 2000.
22. Leonard BL, Evans RG, Navakatikyan MA, and Malpas SC. Differential neural control of intrarenal blood flow. Am J Physiol Regul Integr Comp Physiol 279: R907-R916, 2000.
23. Ludbrook J. On making multiple comparisons in clinical and experimental pharmacology and physiology. Clin Exp Pharmacol Physiol 18: 379-392, 1991.
24. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28: 303-311, 1994.
25. Mattson DL. Importance of the renal medullary circulation in the control of sodium excretion and blood pressure. Am J Physiol Regul Integr Comp Physiol 284: R13-R27, 2003.
26. McGiff JC, Quilley CP, and Carroll MA. The contribution of cytochrome P450-dependent arachidonate metabolites to integrated renal function. Steroids 58: 573-579, 1993.
27. Ogungbade GO, Akinsanmi LA, Jiang H, and Oyekan AO. Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat. Am J Physiol Renal Physiol 285: F955-F964, 2003.
28. Oliver JJ, Eppel GA, Rajapakse NW, and Evans RG. Lipoxygenase and cyclooxygenase products in the control of regional kidney blood flow in rabbits. Clin Exp Pharmacol Physiol 30: 812-819, 2003.
29. Oliver JJ, Rajapakse NW, and Evans RG. Effects of indomethacin on responses of regional kidney perfusion to vasoactive agents in rabbits. Clin Exp Pharmacol Physiol 29: 873-879, 2002.
30. Omata K, Abraham NG, Escalante B, and Schwartzman ML. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 262: F8-F16, 1992.
31. Oyekan AO. Cytochrome P450-dependent metabolites of arachidonic acid and renal function in the rat. Clin Exp Pharmacol Physiol 27: 581-586, 2000.
32. Oyekan AO and McGiff JC. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat. Am J Physiol Regul Integr Comp Physiol 274: R52-R61, 1998.
33. Parekh N, Dobrowolski L, Zou AP, and Steinhausen M. Nitric oxide modulates angiotensin II-and norepinephrine-dependent vasoconstriction in rat kidney. Am J Physiol Regul Integr Comp Physiol 270: R630-R635, 1996.
34. Parekh N and Zou AP. Role of prostaglandins in renal medullary circulation: response to different vasoconstrictors. Am J Physiol Renal Fluid Electrolyte Physiol 271: F653-F658, 1996.
35. Pomposiello SI, Quilley J, Carroll MA, Falck JR, and McGiff JC. 5,6-Epoxyeicosatrienoic acid mediates the enhanced renal vasodilatation to arachidonic acid in the SHR. Hypertension 42: 548-554, 2003.
36. Rajapakse NW, Oliver JJ, and Evans RG. Nitric oxide in responses of regional kidney blood flow to vasoactive agents in anesthetized rabbits. J Cardiovasc Pharmacol 40: 210-219, 2002.
37. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
38. Ronis MJJ, Huang J, Longo V, Tindberg N, Ingelman-Sundberg M, and Badger TM. Expression and distribution of cytochrome P-450 enzymes in male rat kidney: effects of ethanol, acetone and dietary conditions. Biochem Pharmacol 55: 123-129, 1998.
39. +)ATPase. Nature 314: 620-622, 1985.
40. Stec DE, Flasch A, Roman RJ, and White JA. Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice. Am J Physiol Renal Physiol 284: F95-F102, 2003.
41. Takahashi K, Capdevila J, Karara A, Falck JR, Jacobson HR, and Badr KF. Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses. Am J Physiol Renal Fluid Electrolyte Physiol 258: F781-F789, 1990.
42. Vazquez B, Rios A, and Escalante B. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. Life Sci 56: 1455-1466, 1995.
43. Walker LL, Rajaratne AA, Blair-West JR, and Harris PJ. The effects of angiotensin II on blood perfusion in the rat renal papilla. J Physiol 519: 273-278, 1999.
44. Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, and Schwartzman ML. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther 284: 966-973, 1998.
45. Yu Z, Huse LM, Adler P, Graham L, Ma J, Zeldin DC, and Kroetz DL. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney. Mol Pharmacol 57: 1011-1020, 2000.
46. +-channel activity. Am J Physiol Renal Fluid Electrolyte Physiol 270: F822-F832, 1996.
47. Zou AP, Ma YH, Sui ZH, Ortiz de Montellano PR, Clark JE, Masters BS, and Roman RJ. Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function in rats. J Pharmacol Exp Ther 268: 474-481, 1994.
48. Zou AP, Muirhead EE, Cowley AW, Mattson DL, Falck JR, Jiang J, and Roman RJ. Role of changes in renal hemodynamics and P-450 metabolites of arachidonic acid in the reversal of one-kidney, one clip hypertension. J Hypertens 13: 557-566, 1995.
49. Zou AP, Wu F, and Cowley AW Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 31: 271-276, 1997.